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Introduction 
Reexpansion pulmonary edema (REPE) 
is a rare, but well reported complication of 
pleural effusion1 and a number of articles 
reporting hepatic hydrothorax with minimal 
ascites have been published.2-6 To our 
knowledge, there are no reports of REPE 
occurring after therapeutic thoracentesis of 
hepatic hydrothorax in the setting of 
minimal ascites.  
The development of hepatic hydrothorax 
is thought to be due to the passage of 
transudative fluid from the peritoneal cavity 
to the pleural cavity through diaphragmatic 
defects.7 In the absence of ascites, rapid 
fluid shifts from the peritoneum to pleural 
cavity are thought to take place due to a 
combination of elevated intraperitoneal 
pressure and negative pressure in the pleural 
space resulting in hepatic hydrothorax with 
minimal ascites.8  
We present a case with a rare 
presentation of hepatic hydrothorax 
complicated by both reexpansion pulmonary 
edema and pneumothorax.   
 
Case Report 
A 52-year-old female with a history of 
end stage liver disease (ESLD) presented to 
the emergency department with a chief 
complaint that she “could not get air.” She 
reported a five-day worsening of shortness 
of air, dyspnea with minimal conversation, 
4-pillow orthopnea, chest pain when laying 
supine,  and  a  non-productive  cough.   She  
 
denied fevers, chills, and night sweats, but 
reported a significant weight gain of 15 
pounds in the prior 10 days.  
Her past medical history was significant 
for ESLD secondary to primary sclerosing 
cholangitis, portal hypertension, ulcerative 
colitis, and insulin dependent diabetes 
mellitus type II. She was hospitalized one 
week earlier for melena and anemia 
(hemoglobin 6.0 mg/dL) that required 
transfusion of four units of packed red blood 
cells. Endoscopy revealed only grade 1 
esophageal varices. She denied alcohol, 
tobacco, or illicit drug use and family 
history was significant for lung cancer, 
liposarcoma, and colon cancer.  
Vital signs included a temperature of 
37˚C, blood pressure of 165/94 mmHg, 
pulse of 107 beats/min, respiratory rate of 22 
breaths/min, and an O2 saturation of 95% on 
room air. She was in mild respiratory 
distress; her sclera was anicteric. Heart rate 
was regular with a 2/6 systolic ejection 
murmur. Lungs were clear to auscultation on 
the left with no breath sounds and dullness 
to percussion throughout the right hemi-
thorax. Her abdomen was soft, diffusely 
tender to palpation, and non-distended. 
Bilateral lower extremity edema was noted, 
cranial nerves were intact, and there was no 
asterixis.  
A complete blood count was significant 
only for mild anemia with hemoglobin of 
10.2 mg/dL. A comprehensive metabolic 
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panel revealed potassium of 3.2 mg/dL, total 
bilirubin 2.8 mg/dL, and albumin 1.3 mg/dL. 
Her calculated Model for End Stage Liver 
Disease (MELD) score was 14.  
A chest x-ray showed a large right 
pleural effusion (Figure 1). Computed 
tomography (CT) of the chest and abdomen 
showed massive right pleural effusion and 
complete atelectasis of the right lung in 
addition to cirrhosis, portal venous hyper-
tension, splenomegaly, mild peri-hepatic 
ascites, and gastroesophageal varices. 
Thoracentesis was performed and two liters 
of clear yellow fluid was aspirated and 
determined to be transudative by Light’s 
criteria9 with a pleural fluid/serum total 
protein ratio less than 0.5, pleural 
fluid/serum LDH ratio less than 0.6, and 
serum-to-pleural-fluid albumin gradient 
greater than 1.1. Due to the transudative 
nature of the fluid and the right-sided 
accumulation, the effusion was deemed 
likely hepatic hydrothorax.  
 
 
Figure 1.  Right-sided pleural effusion. 
 
Shortly after the procedure, the patient 
began coughing. A follow-up chest x-ray 
showed a right apical pneumothorax and the 
patient was started on 100% non-rebreather 
mask (Figure 2). Due to persistence of the 
cough and continued respiratory distress, 
another chest x-ray was obtained, revealing 
increased edema on the right upper lobe 
consistent with reexpansion pulmonary 
edema (Figure 3). 
 
 
Figure 2. Development of small right apical 
pneumothorax status post thoracentesis. 
 
 
Figure 3. Development of reexpansion 
pulmonary edema (arrow denotes small 
residual pneumothorax). 
 
The goal of management initially should 
be to control the formation of transudative 
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fluid. Therefore, the patient was started on 
furosemide and spironolactone, placed on 
1.5 liter fluid restriction, and a two gram 
sodium restriction diet. Over the course of 
four days, serial chest x-rays showed 
gradual improvement with complete 
resolution of the pulmonary edema and 
pleural effusion (Figure 4). The patient was 
discharged to home in stable condition and 
able to ambulate with good oxygen 
saturations on room air.  
 
 
Figure 4. Resolution of pulmonary edema 
and pleural effusion after diuresis. 
 
Discussion 
There are situations in which the 
effusion is refractory to medical treatment 
alone. In these cases, serial thoracentesis is 
recommended. When thoracentesis is 
needed more frequently than every two to 
three weeks, alternative treatment options 
should be discussed.10 While definitive 
treatment is orthotopic liver transplant-
ation,11 options including transjugular 
intrahepatic portosystemic shunt (TIPS)12 
and video-assisted thorascopy (VATS)13 to 
repair diaphragmatic defects with and 
without pleurodesis have been identified as 
the best available “bridging” procedures for 
those awaiting transplantation.14 Chest tube 
placement has long been considered a 
relative contraindication in the treatment of 
hepatic hydrothorax.15  
Prevention of complications associated 
with thoracentesis is not well-known, given 
the different circumstances contributing to a 
pleural effusion. Pneumo-thorax is the most 
common complication.16 Reexpansion pul-
monary edema has been studied, and there 
are some potential prevention recom-
mendations available, including taking into 
account the duration of time the effusion has 
been present, the presence of underlying 
lung disease, the pleural pressure, and the 
presence of symptoms while doing the 
thoracentesis.17 In general, consensus 
appears to be that less than 1.5 liters should 
be removed, unless pleural pressures are 
used for guidance. 
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